{"nct_id":"NCT05451810","title":"A Study to Evaluate Adverse Events of Subcutaneous (SC) Epcoritamab Administered in the Outpatient Setting in Adult Participants With Relapsed or Refractory Diffuse Large B-Cell Lymphoma and Classic Follicular Lymphoma","status":"ACTIVE_NOT_RECRUITING","status_verified_date":"2025-01","start_date":"2022-08-17","start_date_type":"ACTUAL","primary_completion_date":"2027-03","primary_completion_date_type":"ESTIMATED","completion_date":"2027-03","completion_date_type":"ESTIMATED","phases":["PHASE2"],"tickers":["GMAB"]}